Literature DB >> 4073937

Continuing respiratory problems three and a half years after acute viral bronchiolitis.

M S Webb, R L Henry, A D Milner, G M Stokes, A S Swarbrick.   

Abstract

We reviewed the clinical progress of 81 children as part of a prospective study three and a half years after admission to hospital with acute viral bronchiolitis in infancy. Fifty six (69%) reported episodes of lower respiratory symptoms continuing over the preceding year, 25 (31%) had symptoms lasting for longer than two weeks on two or more occasions, 14 (17%) had symptoms for more than 100 days, and six (7%) required readmission to hospital with acute respiratory illness. Two years previously, these percentages had been 82%, 36%, 33%, and 13% respectively. Forty six (57%) children were said to be improving or to have become asymptomatic, but eight (10%) were deteriorating. There was no difference in the personal or family history of atopy, nor in the rate of skin test positivity between those with and without continuing symptoms, suggesting that atopy does not play an important role in the persistence of symptoms. Less than half the symptomatic children had received bronchodilator treatment during the preceding 12 months.

Entities:  

Mesh:

Year:  1985        PMID: 4073937      PMCID: PMC1777618          DOI: 10.1136/adc.60.11.1064

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  15 in total

1.  Epidemiologic evidence that childhood problems predispose to airways disease in the adult (an association between adult and pediatric respiratory disorders).

Authors:  B Burrows; M D Lebowitz; R J Knudson
Journal:  Pediatr Res       Date:  1977-03       Impact factor: 3.756

2.  Wheezing, asthma, and pulmonary dysfunction 10 years after infection with respiratory syncytial virus in infancy.

Authors:  C R Pullan; E N Hey
Journal:  Br Med J (Clin Res Ed)       Date:  1982-06-05

3.  Lung function abnormalities after acute bronchiolitis.

Authors:  G M Stokes; A D Milner; I G Hodges; R C Groggins
Journal:  J Pediatr       Date:  1981-06       Impact factor: 4.406

4.  Genetic factors in childhood asthma.

Authors:  B Sibbald; M E Horn; E A Brain; I Gregg
Journal:  Thorax       Date:  1980-09       Impact factor: 9.139

5.  Bronchiolitis as a possible cause of wheezing in childhood: new evidence.

Authors:  K M McConnochie; K J Roghmann
Journal:  Pediatrics       Date:  1984-07       Impact factor: 7.124

6.  Parental smoking and respiratory illness in infancy.

Authors:  D M Fergusson; L J Horwood; F T Shannon
Journal:  Arch Dis Child       Date:  1980-05       Impact factor: 3.791

7.  Atopy does not predispose to RSV bronchiolitis or postbronchiolitic wheezing.

Authors:  D G Sims; P S Gardner; D Weightman; M W Turner; J F Soothill
Journal:  Br Med J (Clin Res Ed)       Date:  1981-06-27

8.  Outcome of acute lower respiratory tract infection in infants: preliminary report of seven-year follow-up study.

Authors:  J Y Mok; H Simpson
Journal:  Br Med J (Clin Res Ed)       Date:  1982-07-31

9.  Atopy predisposing to acute bronchiolitis during an epidemic of respiratory syncytial virus.

Authors:  I Laing; F Reidel; P L Yap; H Simpson
Journal:  Br Med J (Clin Res Ed)       Date:  1982-04-10

10.  Underdiagnosis and undertreatment of asthma in childhood.

Authors:  A N Speight; D A Lee; E N Hey
Journal:  Br Med J (Clin Res Ed)       Date:  1983-04-16
View more
  27 in total

Review 1.  The respiratory syncitial virus and its role in acute bronchiolitis.

Authors:  M L Everard; A D Milner
Journal:  Eur J Pediatr       Date:  1992-09       Impact factor: 3.183

2.  Respiratory status and allergy nine to 10 years after acute bronchiolitis.

Authors:  V Noble; M Murray; M S Webb; J Alexander; A S Swarbrick; A D Milner
Journal:  Arch Dis Child       Date:  1997-04       Impact factor: 3.791

3.  Respiratory syncytial virus influences NF-kappaB-dependent gene expression through a novel pathway involving MAP3K14/NIK expression and nuclear complex formation with NF-kappaB2.

Authors:  Sanjeev Choudhary; Steve Boldogh; Roberto Garofalo; Mohammad Jamaluddin; Allan R Brasier
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

4.  Respiratory status and allergy after bronchiolitis.

Authors:  M Murray; M S Webb; C O'Callaghan; A S Swarbrick; A D Milner
Journal:  Arch Dis Child       Date:  1992-04       Impact factor: 3.791

Review 5.  Economic and long-term benefits of ribavirin therapy on respiratory syncytial virus infection.

Authors:  N J Snell
Journal:  Lung       Date:  1990       Impact factor: 2.584

6.  The major component of IkappaBalpha proteolysis occurs independently of the proteasome pathway in respiratory syncytial virus-infected pulmonary epithelial cells.

Authors:  M Jamaluddin; A Casola; R P Garofalo; Y Han; T Elliott; P L Ogra; A R Brasier
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

Review 7.  Ribavirin and acute bronchiolitis in infancy.

Authors:  A D Milner
Journal:  BMJ       Date:  1988-10-22

8.  Subversion of pulmonary dendritic cell function by paramyxovirus infections.

Authors:  Antonieta Guerrero-Plata; Deepthi Kolli; Chao Hong; Antonella Casola; Roberto P Garofalo
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

9.  CD4+ T cells clear virus but augment disease in mice infected with respiratory syncytial virus. Comparison with the effects of CD8+ T cells.

Authors:  W H Alwan; F M Record; P J Openshaw
Journal:  Clin Exp Immunol       Date:  1992-06       Impact factor: 4.330

10.  Lung function, airway responsiveness, and respiratory symptoms before and after bronchiolitis.

Authors:  S Young; P T O'Keeffe; J Arnott; L I Landau
Journal:  Arch Dis Child       Date:  1995-01       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.